Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome

Chin Med J (Engl). 2019 Mar 20;132(6):753-754. doi: 10.1097/CM9.0000000000000130.

Authors

Nicholas G Kounis¹, Ioanna Koniari², Panagiotis Plotas³, George D Soufras⁴, Grigorios Tsigkas¹, Periklis Davlouros¹, George Hahalis¹

Affiliations

¹ Department of Cardiology, University of Patras Medical School, Rion, Patras, Achaia, Greece.
² Department of Electrophysiology, Queen Elizabeth Hospital, Birmingham, England, United Kingdom.
³ Department of Public Health, School of Medicine, University of Patras, Greece.
⁴ Department of Cardiology, "Saint Andrews" State General Hospital, Patras, Achaia, Greece.

No abstract available

Publication types

Case Reports

MeSH terms

Afatinib / therapeutic use
Carcinoma, Squamous Cell / drug therapy
Cardiotoxicity
China
Cisplatin / therapeutic use
Coronary Artery Disease / drug therapy
Deoxycytidine / analogs & derivatives
Deoxycytidine / therapeutic use
Gemcitabine
Humans
Kounis Syndrome / drug therapy
Male
Medical Oncology / statistics & numerical data*
Medical Oncology / trends*
Middle Aged

Substances

Deoxycytidine
Afatinib
Cisplatin
Gemcitabine